论文信息 - Updated European Consensus Statement on diagnosis and treatment of adult ADHD

Updated European Consensus Statement on diagnosis and treatment of adult ADHD

[1] C. Kan,et al. The Efficacy of Adapted MBCT on Core Symptoms and Executive Functioning in Adults With ADHD: A Preliminary Randomized Controlled Trial , 2019, Journal of attention disorders.

[2] S. Maltezos,et al. Validation of the Mind Excessively Wandering Scale and the Relationship of Mind Wandering to Impairment in Adult ADHD , 2016, Journal of attention disorders.

[3] F. Shokraneh,et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis , 2018, The lancet. Psychiatry.

[4] P. Asherson,et al. Mind wandering perspective on attention-deficit/hyperactivity disorder , 2018, Neuroscience & Biobehavioral Reviews.

[5] K. Nilsson,et al. Diagnosing ADHD in Adults: An Examination of the Discriminative Validity of Neuropsychological Tests and Diagnostic Assessment Instruments , 2018, Journal of attention disorders.

[6] R. Cunill,et al. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. , 2018, The Cochrane database of systematic reviews.

[7] Tamsin Ford,et al. Transitioning from child and adolescent mental health services with attention‐deficit hyperactivity disorder in Ireland: Case note review , 2018, Early intervention in psychiatry.

[8] M. O’Donovan,et al. Investigating late‐onset ADHD: a population cohort investigation , 2018, Journal of child psychology and psychiatry, and allied disciplines.

[9] A. Beekman,et al. The Burden of ADHD in Older Adults: A Qualitative Study , 2018, Journal of attention disorders.

[10] W. van den Brink,et al. International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder , 2018, European Addiction Research.

[11] S. Hernández-Díaz,et al. Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium , 2017, JAMA psychiatry.

[12] J. Swanson,et al. Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25. , 2017, The American journal of psychiatry.

[13] K. Klungsøyr,et al. Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review , 2016, Journal of attention disorders.

[14] G. Szycik,et al. Comorbidity of Internet use disorder and attention deficit hyperactivity disorder: Two adult case–control studies , 2017, Journal of behavioral addictions.

[15] J. Swanson,et al. Late-Onset ADHD: Understanding the Evidence and Building Theoretical Frameworks , 2017, Current Psychiatry Reports.

[16] Philip Shaw,et al. Multimodal mapping of the brain’s functional connectivity and the adult outcome of attention deficit hyperactivity disorder , 2017, Proceedings of the National Academy of Sciences.

[17] K. Klungsøyr,et al. Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study , 2017, European Child and Adolescent Psychiatry.

[18] A. Koyanagi,et al. Attention-deficit/hyperactivity disorder and physical multimorbidity: A population-based study , 2017, European Psychiatry.

[19] S. Bölte,et al. Psychoeducational groups for adults with ADHD and their significant others (PEGASUS): A pragmatic multicenter and randomized controlled trial , 2017, European Psychiatry.

[20] A. Sjölander,et al. ADHD Medication and Substance-Related Problems. , 2017, The American journal of psychiatry.

[21] Jakob Grove,et al. Discovery of the first genome-wide significant risk loci for ADHD , 2017, bioRxiv.

[22] B. Franke,et al. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults - Authors' reply. , 2017, The lancet. Psychiatry.

[23] A. Sjölander,et al. Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes , 2017, JAMA psychiatry.

[24] Cynthia Rudin,et al. The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5 , 2017, JAMA psychiatry.

[25] A. Young,et al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017 , 2017, Journal of psychopharmacology.

[26] M. Thase,et al. The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder. , 2017, The American journal of psychiatry.

[27] T. Chalder,et al. Fatigue in an adult attention deficit hyperactivity disorder population: A trans‐diagnostic approach , 2017, The British journal of clinical psychology.

[28] Heidi Aase,et al. Smoking in Pregnancy and Child ADHD , 2017, Pediatrics.

[29] J. Spijker,et al. Sleep and Circadian Rhythmicity in Adult ADHD and the Effect of Stimulants , 2017, Journal of attention disorders.

[30] Mutita Lerdpaisanskul,et al. Self-esteem in children with attention-de fi cit/hyperactivity disorder , 2017 .

[31] R. Stieglitz,et al. Emotional Dysregulation in Adults With Attention-Deficit/Hyperactivity Disorder-Validity, Predictability, Severity, and Comorbidity. , 2017, Journal of clinical psychology.

[32] M. Danckaerts,et al. [A comparative study of the structural stigmatisation of ADHD and autism spectrum disorder in Flemish newspapers]. , 2017, Tijdschrift voor psychiatrie.

[33] M. Cairncross,et al. The Effectiveness of Mindfulness-Based Therapies for ADHD: A Meta-Analytic Review , 2020, Journal of attention disorders.

[34] Alan M. Zaslavsky,et al. The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys , 2017, ADHD Attention Deficit and Hyperactivity Disorders.

[35] P. Lichtenstein,et al. Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study , 2016, Biological Psychiatry.

[36] S. Faraone,et al. An evidenced-based perspective on the validity of attention-deficit/hyperactivity disorder in the context of high intelligence , 2016, Neuroscience & Biobehavioral Reviews.

[37] E. Fuller-Thomson,et al. Attention-deficit/hyperactivity disorder casts a long shadow: findings from a population-based study of adult women with self-reported ADHD. , 2016, Child: care, health and development.

[38] Tom V. Hanley,et al. Childhood Factors Affecting Persistence and Desistence of Attention-Deficit/Hyperactivity Disorder Symptoms in Adulthood: Results From the MTA. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

[39] G. Gudjonsson,et al. A randomized controlled trial reporting functional outcomes of cognitive–behavioural therapy in medication-treated adults with ADHD and comorbid psychopathology , 2016, European Archives of Psychiatry and Clinical Neuroscience.

[40] J. Haavik,et al. Personality Traits and Comorbidity in Adults With ADHD , 2016, Journal of attention disorders.

[41] David M. Evans,et al. A Genome-Wide Association Meta-Analysis of Attention-Deficit/Hyperactivity Disorder Symptoms in Population-Based Pediatric Cohorts. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

[42] A. Ornoy,et al. Methylphenidate in Pregnancy: A Multicenter, Prospective, Comparative, Observational Study. , 2016, The Journal of clinical psychiatry.

[43] M. Tatlow‐Golden,et al. What do general practitioners know about ADHD? Attitudes and knowledge among first-contact gatekeepers: systematic narrative review , 2016, BMC Family Practice.

[44] U. Müller,et al. Recommendations for the transition of patients with ADHD from child to adult healthcare services: a consensus statement from the UK adult ADHD network , 2016, BMC Psychiatry.

[45] W. Pelham,et al. Financial Dependence of Young Adults with Childhood ADHD , 2015, Journal of Abnormal Child Psychology.

[46] D. Bijlenga,et al. ADHD in old age: a review of the literature and proposal for assessment and treatment , 2016, Expert review of neurotherapeutics.

[47] S. Faraone,et al. Can Attention-Deficit/Hyperactivity Disorder Onset Occur in Adulthood? , 2016, JAMA psychiatry.

[48] L. Rohde,et al. Adult attention-deficit hyperactivity disorder: key conceptual issues. , 2016, The lancet. Psychiatry.

[49] B. D’Onofrio,et al. Factors Associated With Adherence to Methylphenidate Treatment in Adult Patients With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders , 2016, Journal of clinical psychopharmacology.

[50] E. Roughead,et al. Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study , 2016, British Medical Journal.

[51] T. Epstein,et al. WITHDRAWN: Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. , 2016, The Cochrane database of systematic reviews.

[52] M. Arns,et al. Editorial Perspective: How should child psychologists and psychiatrists interpret FDA device approval? Caveat emptor. , 2016, Journal of child psychology and psychiatry, and allied disciplines.

[53] V. Reed,et al. A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients , 2016, Journal of psychopharmacology.

[54] M. Lebowitz. Stigmatization of ADHD , 2016, Journal of attention disorders.

[55] Joel L. Young,et al. Supplementary guanfacine hydrochloride as a treatment of attention deficit hyperactivity disorder in adults: A double blind, placebo-controlled study , 2016, Psychiatry Research.

[56] S. Faraone,et al. Assessing the Validity of the Age at Onset Criterion for Diagnosing ADHD in DSM-5 , 2016, Journal of attention disorders.

[57] K. Jørgensen,et al. Cognitive behavioural therapy for ADHD in adults: systematic review and meta-analyses , 2016, ADHD Attention Deficit and Hyperactivity Disorders.

[58] K. Rasmussen,et al. Optimal management of ADHD in older adults , 2016, Neuropsychiatric disease and treatment.

[59] H. Caci,et al. Effect of Treatment Modality on Long-Term Outcomes in Attention-Deficit/Hyperactivity Disorder: A Systematic Review. , 2016, Focus.

[60] J. Bramham,et al. Characterizing adult attention-deficit/hyperactivity-disorder and comorbid borderline personality disorder: ADHD symptoms, psychopathology, cognitive functioning and psychosocial factors , 2016, European Psychiatry.

[61] L. Rohde,et al. Association Between ADHD and Obesity: A Systematic Review and Meta-Analysis. , 2015, The American journal of psychiatry.

[62] Maya D. Guendelman,et al. Childhood Attention-Deficit/Hyperactivity Disorder Predicts Intimate Partner Victimization in Young Women , 2015, Journal of Abnormal Child Psychology.

[63] Jan K Buitelaar,et al. ADHD in Childhood and/or Adulthood as a Risk Factor for Domestic Violence or Intimate Partner Violence: A Systematic Review , 2020, Journal of attention disorders.

[64] B. Franke,et al. Deviant white matter structure in adults with attention-deficit/hyperactivity disorder points to aberrant myelination and affects neuropsychological performance , 2015, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[65] Timothy D. Nelson,et al. Stimulant Medications and Sleep for Youth With ADHD: A Meta-analysis , 2015, Pediatrics.

[66] M. Abdel-Hamid,et al. Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. , 2015, JAMA psychiatry.

[67] A. Ludolph,et al. Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe , 2015, Clinical Drug Investigation.

[68] R. Stieglitz,et al. Attention-Deficit/Hyperactivity Disorder (ADHD) in Adulthood: Concordance and Differences between Self- and Informant Perspectives on Symptoms and Functional Impairment , 2015, PloS one.

[69] N. Makris,et al. Toward Defining the Neural Substrates of ADHD , 2015, Journal of attention disorders.

[70] Jan K. Buitelaar,et al. Cognitive heterogeneity in adult attention deficit/hyperactivity disorder: A systematic analysis of neuropsychological measurements , 2015, European Neuropsychopharmacology.

[71] P. Videbech,et al. Use of psychotropic drugs during pregnancy and breast‐feeding , 2015, Acta psychiatrica Scandinavica. Supplementum.

[72] R. Kuja‐Halkola,et al. Heritability of attention‐deficit hyperactivity disorder in adults , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[73] F. Prevatt,et al. An Empirical Evaluation of ADHD Coaching in College Students , 2015, Journal of attention disorders.

[74] D. Daley,et al. Costing Adult Attention Deficit Hyperactivity Disorder: Impact on the Individual and Society , 2015 .

[75] E. Nunes,et al. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial. , 2015, JAMA psychiatry.

[76] B. Pennington,et al. Sex differences in ADHD symptom severity. , 2015, Journal of child psychology and psychiatry, and allied disciplines.

[77] S. Dalsgaard,et al. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study , 2015, The Lancet.

[78] G. Gudjonsson,et al. Cognitive–behavioural therapy in medication-treated adults with attention-deficit/hyperactivity disorder and co-morbid psychopathology: a randomized controlled trial using multi-level analysis , 2015, Psychological Medicine.

[79] D. Belsky,et al. Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study. , 2015, The American journal of psychiatry.

[80] A. Ghanizadeh. A systematic review of reboxetine for treating patients with attention deficit hyperactivity disorder , 2015, Nordic journal of psychiatry.

[81] M. Toplak,et al. Attention Deficit Hyperactivity Disorder Symptoms, Comorbidities, Substance Use, and Social Outcomes among Men and Women in a Canadian Sample , 2015, BioMed research international.

[82] E. Hennessy,et al. Retrospective accounts of self-stigma experienced by young people with attention-deficit/hyperactivity disorder (ADHD) or depression. , 2015, Psychiatric rehabilitation journal.

[83] M. Rösler,et al. Psychoedukation und Coaching bei ADHS im Erwachsenenalter , 2015, NeuroTransmitter.

[84] Mady Hornig,et al. Integration of an EEG biomarker with a clinician's ADHD evaluation , 2015, Brain and behavior.

[85] G. Salum,et al. Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. , 2015, Journal of child psychology and psychiatry, and allied disciplines.

[86] H. Caci,et al. Effect of Treatment Modality on Long-Term Outcomes in Attention-Deficit/Hyperactivity Disorder: A Systematic Review , 2015, PloS one.

[87] Nico Bunzeck,et al. Altered salience processing in attention deficit hyperactivity disorder , 2015, Human brain mapping.

[88] P. Shaw,et al. White Matter Microstructure and the Variable Adult Outcome of Childhood Attention Deficit Hyperactivity Disorder , 2015, Neuropsychopharmacology.

[89] J. Olsen,et al. Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy , 2015, Clinical epidemiology.

[90] Daniel Smilek,et al. On the relation of mind wandering and ADHD symptomatology , 2015, Psychonomic bulletin & review.

[91] R. Cunill,et al. Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence , 2015, Journal of psychopharmacology.

[92] C. Hollis,et al. Services for young people with attention deficit/hyperactivity disorder transitioning from child to adult mental health services: A national survey of mental health trusts in England , 2015, Journal of psychopharmacology.

[93] D. Bijlenga,et al. Objective QbTest and subjective evaluation of stimulant treatment in adult attention deficit-hyperactivity disorder , 2015, European Psychiatry.

[94] D. Coghill. Services for adults with ADHD: work in progress† , 2014, BJPsych Bulletin.

[95] G. Gudjonsson,et al. Cognitive – behavioural therapy in medication-treated adults with attention-de fi cit / hyperactivity disorder and co-morbid psychopathology : a randomized controlled trial using multi-level analysis , 2015 .

[96] Jan K. Buitelaar,et al. Attention-deficit/hyperactivity disorder , 2015, Nature Reviews Disease Primers.

[97] Sara N. Mitchell,et al. Clinical Presentation, Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Older Adults: A Review of the Evidence and its Implications for Clinical Care , 2015, Drugs & Aging.

[98] A. Sjölander,et al. Maternal age at childbirth and risk for ADHD in offspring: a population-based cohort study. , 2014, International journal of epidemiology.

[99] M. Pennick,et al. Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells , 2014, Neuropsychiatric disease and treatment.

[100] W. van den Brink,et al. Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms. , 2014, Drug and alcohol dependence.

[101] E. Bullmore,et al. Neuroanatomical Abnormalities and Cognitive Impairments Are Shared by Adults with Attention-Deficit/Hyperactivity Disorder and Their Unaffected First-Degree Relatives , 2014, Biological Psychiatry.

[102] M. Srisurapanont,et al. Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD , 2014, Drug design, development and therapy.

[103] S. Faraone,et al. Attention-Deficit/Hyperactivity Disorder and Adverse Health Outcomes in Adults , 2014, The Journal of nervous and mental disease.

[104] X. Castells,et al. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents. , 2014, The Cochrane database of systematic reviews.

[105] Susan Young and Jessica Bramham.. Cognitive-behavioural therapy for ADHD in adolescents and adults : , 2014 .

[106] T. Ford,et al. Transition from child and adolescent to adult mental health services in the Republic of Ireland: an investigation of process and operational practice , 2014, Early intervention in psychiatry.

[107] P. Lichtenstein,et al. Stimulant ADHD medication and risk for substance abuse. , 2014, Journal of child psychology and psychiatry, and allied disciplines.

[108] N. Maneeton,et al. A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder , 2014, Neuropsychiatric disease and treatment.

[109] J. Thome,et al. Adult ADHD and suicide , 2014, ADHD Attention Deficit and Hyperactivity Disorders.

[110] P. Asherson,et al. Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trials , 2014, Journal of psychopharmacology.

[111] Jan K Buitelaar,et al. Different mechanisms of white matter abnormalities in attention-deficit/hyperactivity disorder: a diffusion tensor imaging study. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

[112] F. Manes,et al. Dysfunctional Cognitions and their Emotional, Behavioral, and Functional Correlates in Adults with Attention Deficit Hyperactivity Disorder (ADHD) , 2014, Journal of attention disorders.

[113] M. Freeman. ADHD and pregnancy. , 2014, The American journal of psychiatry.

[114] J. Buitelaar,et al. Effects of mindfulness-based cognitive therapy on neurophysiological correlates of performance monitoring in adult attention-deficit/hyperactivity disorder , 2014, Clinical Neurophysiology.

[115] A. Sjölander,et al. Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study , 2014, BMJ : British Medical Journal.

[116] F. Rijsdijk,et al. Shared Cognitive Impairments and Aetiology in ADHD Symptoms and Reading Difficulties , 2014, PloS one.

[117] S. Bölte,et al. Cognitive behavior therapy-based psychoeducational groups for adults with ADHD and their significant others (PEGASUS): an open clinical feasibility trial , 2014, ADHD Attention Deficit and Hyperactivity Disorders.

[118] F. Besag. ADHD Treatment and Pregnancy , 2014, Drug Safety.

[119] Elizabeth B. Owens,et al. Pathways to self-harmful behaviors in young women with and without ADHD: a longitudinal examination of mediating factors. , 2014, Journal of child psychology and psychiatry, and allied disciplines.

[120] A. Hansen,et al. Use of ADHD medication during pregnancy from 1999 to 2010: a Danish register‐based study , 2014, Pharmacoepidemiology and drug safety.

[121] D. Coghill,et al. A Systematic Review of the Safety of Lisdexamfetamine Dimesylate , 2014, CNS Drugs.

[122] S. Young,et al. A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations , 2014, Psychological Medicine.

[123] W. Gouvier,et al. “Why Is This So Hard?” A Review of Detection of Malingered ADHD in College Students , 2014, Journal of attention disorders.

[124] Icilio Cavero,et al. Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating cardiac valvulopathy. , 2014, Journal of pharmacological and toxicological methods.

[125] A. Sjölander,et al. Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. , 2014, JAMA psychiatry.

[126] B. Franke,et al. Brain alterations in adult ADHD: Effects of gender, treatment and comorbid depression , 2014, European Neuropsychopharmacology.

[127] K. Rubia,et al. Brain abnormalities in attention-deficit hyperactivity disorder: a review. , 2014, Revista de neurologia.

[128] D. Nutt,et al. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology , 2014, Journal of psychopharmacology.

[129] S. Faraone,et al. Childhood and persistent ADHD symptoms associated with educational failure and long-term occupational disability in adult ADHD , 2014, ADHD Attention Deficit and Hyperactivity Disorders.

[130] L. Adler,et al. A 9-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD , 2014, Journal of attention disorders.

[131] H. Steinhausen,et al. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample , 2014, European Neuropsychopharmacology.

[132] V. Pérez,et al. Pharmacological and clinical dilemmas of prescribing in co‐morbid adult attention‐deficit/hyperactivity disorder and addiction , 2014, British journal of clinical pharmacology.

[133] Alok Sharma,et al. A Review of the Pathophysiology, Etiology, and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) , 2014, The Annals of pharmacotherapy.

[134] J. Hallas,et al. First-trimester exposure to methylphenidate: a population-based cohort study. , 2014, The Journal of clinical psychiatry.

[135] K. Lange,et al. Stigmatization in teachers towards adults with attention deficit hyperactivity disorder , 2014, SpringerPlus.

[136] C. Goodheart. A Primer for ICD-10-CM Users: Psychological and Behavioral Conditions , 2014 .

[137] B. Bolea-Alamanac,et al. Methylphenidate use in pregnancy and lactation: a systematic review of evidence , 2014, British journal of clinical pharmacology.

[138] J. Franck,et al. Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial , 2013, Addiction.

[139] T. Epstein,et al. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. , 2014, The Cochrane database of systematic reviews.

[140] P. Quinn,et al. A review of attention-deficit/hyperactivity disorder in women and girls: uncovering this hidden diagnosis. , 2014, The primary care companion for CNS disorders.

[141] S. Akhondzadeh,et al. Bupropion in adults with Attention-Deficit/Hyperactivity Disorder: a randomized, double-blind study. , 2014, Acta medica Iranica.

[142] G. Giaroli,et al. To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit/hyperactivity disorder. , 2013, Journal of child and adolescent psychopharmacology.

[143] J. Swanson,et al. Clinical practice: Adult attention deficit-hyperactivity disorder. , 2013, The New England journal of medicine.

[144] F. Castellanos,et al. White Matter Alterations at 33-Year Follow-Up in Adults with Childhood Attention-Deficit/Hyperactivity Disorder , 2013, Biological Psychiatry.

[145] P. Lichtenstein,et al. The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan , 2013, Psychological Medicine.

[146] D. Bijlenga,et al. The circadian rhythm in adult attention-deficit/hyperactivity disorder: current state of affairs , 2013, Expert review of neurotherapeutics.

[147] T. Banaschewski,et al. Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies , 2013, BMC Psychiatry.

[148] R. Cunill,et al. Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta‐analysis and meta‐regression , 2013, Pharmacoepidemiology and drug safety.

[149] N. Makris,et al. Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies. , 2013, The Journal of clinical psychiatry.

[150] L. Adler,et al. Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study. , 2013, The Journal of clinical psychiatry.

[151] H. Kraemer,et al. A Decade of EEG Theta/Beta Ratio Research in ADHD , 2013, Journal of attention disorders.

[152] D. McManus,et al. Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adults , 2013, European Neuropsychopharmacology.

[153] S. Faraone,et al. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: A review of controlled and naturalistic studies , 2013, European Neuropsychopharmacology.

[154] A. Beekman,et al. Attention‐Deficit/Hyperactivity Disorder, Physical Health, and Lifestyle in Older Adults , 2013, Journal of the American Geriatrics Society.

[155] J. Swanson,et al. Long-Term Stimulant Treatment Affects Brain Dopamine Transporter Level in Patients with Attention Deficit Hyperactive Disorder , 2013, PLoS ONE.

[156] P. Asherson,et al. Emotional lability, comorbidity and impairment in adults with attention-deficit hyperactivity disorder. , 2013, Journal of affective disorders.

[157] P. Hodgkins,et al. Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis , 2013, Journal of medical economics.

[158] T. Brown. A New Understanding of ADHD in Children and Adults: Executive Function Impairments , 2013 .

[159] E. V. van Someren,et al. Associations Between Sleep Characteristics, Seasonal Depressive Symptoms, Lifestyle, and ADHD Symptoms in Adults , 2013, Journal of attention disorders.

[160] C. Hollis,et al. Transition to adult mental health services for young people with Attention Deficit/Hyperactivity Disorder (ADHD): a qualitative analysis of their experiences , 2013, BMC Psychiatry.

[161] P. Lichtenstein,et al. Developmental twin study of attention problems: high heritabilities throughout development. , 2013, JAMA psychiatry.

[162] Intravenous immune globulin in autoimmune and inflammatory diseases. , 2013, The New England journal of medicine.

[163] S. Faraone,et al. Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: a controlled study , 2013, ADHD Attention Deficit and Hyperactivity Disorders.

[164] J. Hallas,et al. First trimester in utero exposure to methylphenidate. , 2013, Basic & clinical pharmacology & toxicology.

[165] K. Stanovich,et al. Practitioner review: do performance-based measures and ratings of executive function assess the same construct? , 2013, Journal of child psychology and psychiatry, and allied disciplines.

[166] H. Hart,et al. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. , 2013, JAMA psychiatry.

[167] D. Kupfer,et al. Psychiatry's integration with medicine: the role of DSM-5. , 2013, Annual review of medicine.

[168] F. Rijsdijk,et al. Different heritabilities but shared etiological influences for parent, teacher and self-ratings of ADHD symptoms: an adolescent twin study , 2013, Psychological Medicine.

[169] K. Meador,et al. Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years , 2011, Epilepsy & Behavior.

[170] J. Thome,et al. Handbook for attention deficit hyperactivity disorder in adults , 2013 .

[171] P. Lichtenstein,et al. Medication for attention deficit-hyperactivity disorder and criminality. , 2013, The New England journal of medicine.

[172] J. Kooij,et al. Adult ADHD , 2013, Springer London.

[173] W. Greiner,et al. Treatment costs of attention deficit hyperactivity disorder in Germany , 2013, The European Journal of Health Economics.

[174] H. Nordahl,et al. Prevalence of comorbid substance use disorder during long-term central stimulant treatment in adult ADHD , 2013, ADHD Attention Deficit and Hyperactivity Disorders.

[175] V. Sikirica,et al. Cost Effectiveness of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder , 2012, CNS Drugs.

[176] J. Kooij. Adult ADHD , 2012, Springer London.

[177] J. Ramos-Quiroga,et al. Laminar Thickness Alterations in the Fronto-Parietal Cortical Mantle of Patients with Attention-Deficit/Hyperactivity Disorder , 2012, PloS one.

[178] A. Sjölander,et al. Medication for attention deficit-hyperactivity disorder and criminality. , 2012, The New England journal of medicine.

[179] H. Hart,et al. Neuroscience and Biobehavioral Reviews Meta-analysis of Fmri Studies of Timing in Attention-deficit Hyperactivity Disorder (adhd) , 2022 .

[180] D. Marks,et al. Diagnosis of ADHD in Adults , 2012, Journal of attention disorders.

[181] J. Ramos-Quiroga,et al. Criterion and concurrent validity of Conners Adult ADHD Diagnostic Interview for DSM-IV (CAADID) Spanish version , 2012 .

[182] J. Ramos-Quiroga,et al. Validez de criterio y concurrente de la versión española de la Conners Adult ADHD Diagnostic Interview for DSM-IV , 2012 .

[183] A. Philipsen. Psychotherapy in adult attention deficit hyperactivity disorder: implications for treatment and research , 2012, Expert review of neurotherapeutics.

[184] Michael P Milham,et al. Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. , 2012, The American journal of psychiatry.

[185] P. Chokka,et al. Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations. , 2012, Current drug abuse reviews.

[186] P. Lichtenstein,et al. Genetic and environmental influences on adult attention deficit hyperactivity disorder symptoms: a large Swedish population-based study of twins , 2012, Psychological Medicine.

[187] A. Beekman,et al. Chapter 2 The Prevalence of Attention-Deficit / Hyperactivity Disorder in Older Adults in The Netherlands , 2015 .

[188] L. Hechtman,et al. Cognitive Behavior Therapy for Adults with Attention-Deficit/Hyperactivity Disorder: A Review of Recent Randomized Controlled Trials , 2012, Current Psychiatry Reports.

[189] Andreas Reif,et al. An association study of sequence variants in the forkhead box P2 (FOXP2) gene and adulthood attention-deficit/hyperactivity disorder in two European samples , 2012, Psychiatric genetics.

[190] A. Fuermaier,et al. Stigma in attention deficit hyperactivity disorder , 2012, ADHD Attention Deficit and Hyperactivity Disorders.

[191] Theodore Wasserman,et al. The Sensitivity and Specificity of Neuropsychological Tests in the Diagnosis of Attention Deficit Hyperactivity Disorder , 2012, Applied neuropsychology. Child.

[192] Arthur N Westover,et al. Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review , 2012, BMC Cardiovascular Disorders.

[193] U. Müller,et al. Systematic review of national and international guidelines on attention-deficit hyperactivity disorder , 2012, Journal of psychopharmacology.

[194] F. J. McClernon,et al. Sex, ADHD symptoms, and smoking outcomes: an integrative model. , 2012, Medical hypotheses.

[195] L. Bauer,et al. Attention deficit hyperactivity symptoms and risky sexual behavior in young adult women , 2012 .

[196] J. Bramham,et al. Cognitive-Behavioural Therapy for ADHD in Adolescents and Adults: A Psychological Guide to Practice , 2012 .

[197] J. Rossi,et al. Double-Blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in College Students With ADHD , 2012, Journal of attention disorders.

[198] F. Prevatt,et al. The Positive Illusory Bias , 2012, Journal of attention disorders.

[199] R. Tannock,et al. Altered cortical morphology in sensorimotor processing regions in adolescents and adults with attention-deficit/hyperactivity disorder , 2012, Brain Research.

[200] B. Herpertz-Dahlmann,et al. ADHD and delinquency--a developmental perspective. , 2012, Behavioral sciences & the law.

[201] R. Akehurst,et al. Under Diagnosis of Adult ADHD , 2012, Journal of attention disorders.

[202] Kenneth Hugdahl,et al. Adults with attention-deficit/hyperactivity disorder — A diffusion-tensor imaging study of the corpus callosum , 2012, Psychiatry Research: Neuroimaging.

[203] G. Thornicroft,et al. Systematic review of beliefs, behaviours and influencing factors associated with disclosure of a mental health problem in the workplace , 2012, BMC Psychiatry.

[204] N. Skokauskas,et al. Meta‐analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects , 2012, Acta psychiatrica Scandinavica.

[205] W. Bilker,et al. Methylphenidate and risk of serious cardiovascular events in adults. , 2012, The American journal of psychiatry.

[206] H. J. Olguín,et al. Experimental Models of Developmental Hypothyroidism , 2011, Hormone and Metabolic Research.

[207] Susanne Walitza,et al. Genome-Wide Analysis of Copy Number Variants in Attention Deficit Hyperactivity Disorder: The Role of Rare Variants and Duplications at 15q13.3 , 2012, The American journal of psychiatry.

[208] F. Xavier Castellanos,et al. Large-scale brain systems in ADHD: beyond the prefrontal–striatal model , 2012, Trends in Cognitive Sciences.

[209] B. Franke,et al. The genetics of attention deficit/hyperactivity disorder in adults, a review , 2011, Molecular Psychiatry.

[210] A. Mack. Clonidine Extended-Release Tablets for Pediatric Patients With Attention-Deficit/Hyperactivity Disorder , 2012 .

[211] J. Buitelaar,et al. Symptomatic overlap between attention-deficit/hyperactivity disorder and borderline personality disorder in women: the role of temperament and character traits. , 2012, Comprehensive psychiatry.

[212] J. Martínez-Raga,et al. Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder , 2012, CNS Drugs.

[213] Daniel Brandeis,et al. Diagnostic Value of Resting Electroencephalogram in Attention-Deficit/Hyperactivity Disorder Across the Lifespan , 2012, Brain Topography.

[214] J. Ramos-Quiroga,et al. Criterion and concurrent validity of Conners Adult ADHD Diagnostic Interview for DSM-IV (CAADID) Spanish version. , 2012, Revista de psiquiatria y salud mental.

[215] Susanne Walitza,et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder , 2011, Nature Genetics.

[216] P. Stoeter,et al. White matter abnormalities and their impact on attentional performance in adult attention-deficit/hyperactivity disorder , 2012, European Archives of Psychiatry and Clinical Neuroscience.

[217] Bruce H Fireman,et al. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. , 2011, JAMA.

[218] Yong He,et al. Brain gray matter deficits at 33-year follow-up in adults with attention-deficit/hyperactivity disorder established in childhood. , 2011, Archives of general psychiatry.

[219] Katya Rubia,et al. Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. , 2011, The American journal of psychiatry.

[220] J. Thome,et al. ADHD and offenders , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[221] G. Gudjonsson,et al. Cognitive behaviour therapy in medication-treated adults with ADHD and persistent Symptoms: A randomized controlled trial , 2011, BMC psychiatry.

[222] J. Ramos-Quiroga,et al. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults. , 2011, The Cochrane database of systematic reviews.

[223] Conor Liston,et al. Atypical Prefrontal Connectivity in Attention-Deficit/Hyperactivity Disorder: Pathway to Disease or Pathological End Point? , 2011, Biological Psychiatry.

[224] Marisa O. Hollinshead,et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. , 2011, Journal of neurophysiology.

[225] S. Segal,et al. Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD , 2011, Pediatrics.

[226] V. Glauche,et al. Visual cortex abnormalities in adults with ADHD: A structural MRI study , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[227] M. Monuteaux,et al. Gray Matter Alterations in Adults with Attention-Deficit/Hyperactivity Disorder Identified by Voxel Based Morphometry , 2011, Biological Psychiatry.

[228] Fassnacht,et al. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree , 2011, Molecular Psychiatry.

[229] B. Franke,et al. Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. , 2011, The American journal of psychiatry.

[230] T. Hirvikoski,et al. Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial. , 2011, Behaviour research and therapy.

[231] David Rigau,et al. Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder , 2011, CNS drugs.

[232] S. Segal,et al. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. , 2011, Journal of the American Academy of Child and Adolescent Psychiatry.

[233] R. Barkley,et al. Predicting Impairment in Major Life Activities and Occupational Functioning in Hyperactive Children as Adults: Self-Reported Executive Function (EF) Deficits Versus EF Tests , 2011, Developmental neuropsychology.

[234] Nikolaos Koutsouleris,et al. Anterior cingulate cortex gray matter abnormalities in adults with attention deficit hyperactivity disorder: A voxel-based morphometry study , 2011, Psychiatry Research: Neuroimaging.

[235] R. Barkley. Barkley Adult ADHD Rating Scale--IV (BAARS-IV) , 2011 .

[236] N. Lindefors,et al. Attention Deficit Hyperactivity Disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder , 2010, BMC psychiatry.

[237] J. Ramos-Quiroga,et al. Comorbid attention-deficit/hyperactivity disorder in borderline patients defines an impulsive subtype of borderline personality disorder. , 2010, Journal of personality disorders.

[238] Antonio Fernández-Bouzas,et al. Reduced right frontal cortical thickness in children, adolescents and adults with ADHD and its correlation to clinical variables: a cross-sectional study. , 2010, Journal of psychiatric research.

[239] P. Corrigan,et al. Measuring the impact of programs that challenge the public stigma of mental illness. , 2010, Clinical psychology review.

[240] B. Casey,et al. Neurobiology of the adolescent brain and behavior: implications for substance use disorders. , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[241] M. Tehrani-Doost,et al. Efficacy of reboxetine in adults with attention‐deficit/hyperactivity disorder: A randomized, placebo‐controlled clinical trial , 2010, Human psychopharmacology.

[242] H. Stefánsson,et al. Supplementary webappendix , 2018 .

[243] S. Young,et al. Attention-deficit/hyperactivity disorder in persistent criminal offenders: the need for specialist treatment programs , 2010, Expert review of neurotherapeutics.

[244] T. Weaver,et al. Process, outcome and experience of transition from child to adult mental healthcare: multiperspective study , 2010, British Journal of Psychiatry.

[245] Michael Fitzgerald,et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD , 2010, BMC psychiatry.

[246] Laura E. Knouse,et al. Current status of cognitive behavioral therapy for adult attention-deficit hyperactivity disorder. , 2010, The Psychiatric clinics of North America.

[247] L. Rohde,et al. ADHD in a representative sample of the Brazilian population: estimated prevalence and comparative adequacy of criteria between adolescents and adults according to the item response theory , 2010, International journal of methods in psychiatric research.

[248] Susanne Walitza,et al. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[249] Susan Sprich,et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. , 2010, JAMA.

[250] R. Barkley,et al. Differential diagnosis of adults with ADHD: the role of executive function and self-regulation. , 2010, The Journal of clinical psychiatry.

[251] A. Fernández-Bouzas,et al. Clinical correlations of grey matter reductions in the caudate nucleus of adults with attention deficit hyperactivity disorder. , 2010, Journal of psychiatry & neuroscience : JPN.

[252] L. Kiemeney,et al. Common variants in the TPH1 and TPH2 regions are not associated with persistent ADHD in a combined sample of 1,636 adult cases and 1,923 controls from four European populations , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[253] L. Kiemeney,et al. An international multicenter association study of the serotonin transporter gene in persistent ADHD , 2010, Genes, brain, and behavior.

[254] L. C. Bidwell,et al. Behavioral performance predicts grey matter reductions in the right inferior frontal gyrus in young adults with combined type ADHD , 2010, Psychiatry Research: Neuroimaging.

[255] J. Rucklidge. Gender differences in attention-deficit/hyperactivity disorder. , 2010, The Psychiatric clinics of North America.

[256] M. Gordijn,et al. Delayed Circadian Rhythm in Adults with Attention-Deficit/Hyperactivity Disorder and Chronic Sleep-Onset Insomnia , 2010, Biological Psychiatry.

[257] S. Faraone,et al. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. , 2010, The Journal of clinical psychiatry.

[258] G. Willemsen,et al. Genetic Epidemiology of Attention Deficit Hyperactivity Disorder (ADHD Index) in Adults , 2010, PloS one.

[259] R. Stieglitz,et al. Therapy-relevant factors in adult ADHD from a cognitive behavioural perspective , 2010, Attention deficit and hyperactivity disorders.

[260] Joyce A Kubik. Efficacy of ADHD Coaching for Adults With ADHD , 2010, Journal of attention disorders.

[261] Peter Stoeter,et al. Disturbed structural connectivity is related to inattention and impulsivity in adult attention deficit hyperactivity disorder , 2010, The European journal of neuroscience.

[262] James L. McClelland,et al. How to cite this article: , 2011 .

[263] G. Bush,et al. Anterior Cingulate Volumetric Alterations in Treatment-Naïve Adults With ADHD , 2010, Journal of attention disorders.

[264] T. Shaikh,et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes , 2010, Molecular Psychiatry.

[265] T. Moffitt,et al. The age at onset of attention deficit hyperactivity disorder. , 2010, The American journal of psychiatry.

[266] H. Kuželová,et al. Attention deficit hyperactivity disorder and eating disorders. , 2010, Prague medical report.

[267] T. Wigal,et al. Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design , 2010, Behavioral and Brain Functions.

[268] R. Klein,et al. Attention-Deficit Hyperactivity Disorder (ADHD) in Adults , 2009 .

[269] David Coghill,et al. The genetics of attention-deficit/hyperactivity disorder , 2009, Expert review of neurotherapeutics.

[270] R. Kilian,et al. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder , 2009, Journal of psychopharmacology.

[271] Swaran P. Singh,et al. Transition of care from child to adult mental health services: the great divide , 2009, Current opinion in psychiatry.

[272] I. Waldman,et al. Candidate gene studies of ADHD: a meta-analytic review , 2009, Human Genetics.

[273] B. Cosyns,et al. Role of echocardiography in toxic heart valvulopathy. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[274] R. Hoyle,et al. The Misuse and Diversion of Prescribed ADHD Medications by College Students , 2009, Journal of attention disorders.

[275] P. Asherson,et al. Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instability , 2009, Expert review of neurotherapeutics.

[276] William Kronenberger,et al. Atomoxetine treatment in adults with attention‐deficit/hyperactivity disorder and comorbid social anxiety disorder , 2009, Depression and anxiety.

[277] J. Wells,et al. Attention deficit hyperactivity disorder and critical incidents in a Scottish prison population , 2009 .

[278] X. Estivill,et al. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB , 2009, Molecular Psychiatry.

[279] M Hoogman,et al. Association of the dopamine transporter (SLC6A3/DAT1) gene 9–6 haplotype with adult ADHD , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[280] T. Brown. ADD/ADHD and impaired executive function in clinical practice , 2008 .

[281] F. J. McClernon,et al. ADHD and Smoking , 2008, Annals of the New York Academy of Sciences.

[282] J. Biederman,et al. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. , 2008, The Journal of clinical psychiatry.

[283] S. Faraone,et al. Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses , 2008, Psychological Medicine.

[284] J Ormel,et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative , 2008, Occupational and Environmental Medicine.

[285] M. Gratacós,et al. Association Study of 10 Genes Encoding Neurotrophic Factors and Their Receptors in Adult and Child Attention-Deficit/Hyperactivity Disorder , 2008, Biological Psychiatry.

[286] M. Rutter,et al. Inattention/Overactivity Following Early Severe Institutional Deprivation: Presentation and Associations in Early Adolescence , 2008, Journal of Abnormal Child Psychology.

[287] W. Pelham,et al. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[288] J. Buitelaar,et al. Reliability, Validity, and Utility of Instruments for Self-Report and Informant Report Concerning Symptoms of ADHD in Adult Patients , 2008, Journal of attention disorders.

[289] C. McDougle,et al. Guanfacine and guanfacine extended release: treatment for ADHD and related disorders. , 2007, CNS drug reviews.

[290] R. Barkley,et al. ADHD in Adults: What the Science Says , 2007 .

[291] M. Rietschel,et al. Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD) , 2007, European Archives of Psychiatry and Clinical Neuroscience.

[292] T. Spencer,et al. Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. , 2007, Journal of child and adolescent psychopharmacology.

[293] F. Middleton,et al. Environmental risk factors for attention‐deficit hyperactivity disorder , 2007, Acta paediatrica.

[294] J. Swanson,et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[295] K. Lesch,et al. Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center , 2007, European Archives of Psychiatry and Clinical Neuroscience.

[296] Nora D. Volkow,et al. Brain dopamine transporter levels in treatment and drug naïve adults with ADHD , 2007, NeuroImage.

[297] E. V. van Someren,et al. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[298] D. Nutt,et al. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology , 2007, Journal of psychopharmacology.

[299] E. Taylor,et al. Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry , 2007, British Journal of Psychiatry.

[300] J. A. Talbott. Internal and external validity of Attention-Deficit Hyperactivity Disorder in a population-based sample of adults , 2007 .

[301] D. Cox,et al. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. , 2007, Journal of safety research.

[302] B. Neale,et al. The IMAGE project: methodological issues for the molecular genetic analysis of ADHD , 2006, Behavioral and Brain Functions.

[303] Lin He,et al. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). , 2006, Human molecular genetics.

[304] M. Drummond,et al. A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. , 2006, Health technology assessment.

[305] L. Hechtman,et al. A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults. , 2006, The Journal of clinical psychiatry.

[306] G. Willemsen,et al. Genetic etiology of stability of attention problems in young adulthood , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[307] Susan Sprich,et al. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. , 2005, Behaviour research and therapy.

[308] P. Asherson. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults , 2005, Expert review of neurotherapeutics.

[309] M. Prasad,et al. A review of the economic burden of ADHD , 2005, Cost effectiveness and resource allocation : C/E.

[310] J. Smoller,et al. Molecular Genetics of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[311] N. Makris,et al. Structural Brain Imaging of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[312] Joseph Biederman,et al. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies , 2005, Psychological Medicine.

[313] J. Kenemans,et al. The pure electrophysiology of stopping. , 2005, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[314] R. Kessler,et al. Costs of attention deficit–hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000 , 2005, Current medical research and opinion.

[315] K. B. Heijden,et al. Idiopathic Chronic Sleep Onset Insomnia in Attention‐Deficit/Hyperactivity Disorder: A Circadian Rhythm Sleep Disorder , 2005, Chronobiology international.

[316] J. Hay,et al. Cost effectiveness of methylphenidate versus AMP/DEX mixed salts for the first-line treatment of ADHD , 2004, Expert review of pharmacoeconomics & outcomes research.

[317] H. Birnbaum,et al. Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients. , 2004, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[318] A. While,et al. Good practices that address continuity during transition from child to adult care: synthesis of the evidence. , 2004, Child: care, health and development.

[319] J L Kenemans,et al. Stopping and changing in adults with ADHD , 2004, Psychological Medicine.

[320] T. Vos,et al. Cost-Effectiveness of Dexamphetamine and Methylphenidate for the Treatment of Childhood Attention Deficit Hyperactivity Disorder , 2004 .

[321] T. Vos,et al. Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorder. , 2004, The Australian and New Zealand journal of psychiatry.

[322] L. Seidman,et al. Neuropsychological function in adults with attention-deficit/hyperactivity disorder. , 2004, The Psychiatric clinics of North America.

[323] S. Faraone. Genetics of adult attention-deficit/hyperactivity disorder. , 2004, The Psychiatric clinics of North America.

[324] George Bush,et al. Brain function and structure in adults with attention-deficit/hyperactivity disorder. , 2004, The Psychiatric clinics of North America.

[325] D. Boomsma,et al. Heritability of attention problems in children: longitudinal results from a study of twins, age 3 to 12. , 2004, Journal of child psychology and psychiatry, and allied disciplines.

[326] R. Klein,et al. Persistence of Attention-Deficit/Hyperactivity Disorder into adulthood: What have we learned from the prospective follow-up studies? , 2003, Journal of attention disorders.

[327] C. Gillberg,et al. Deficits in attention, motor control, and perception: a brief review , 2003, Archives of disease in childhood.

[328] P. Hazell,et al. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

[329] L. Weyandt,et al. The Internal Restlessness Scale , 2003, Journal of learning disabilities.

[330] Joseph Biederman,et al. The worldwide prevalence of ADHD: is it an American condition? , 2003, World psychiatry : official journal of the World Psychiatric Association.

[331] R. Barkley,et al. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. , 2002, Journal of abnormal psychology.

[332] Joseph Biederman,et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. , 2002, The American journal of psychiatry.

[333] T. Einarson,et al. Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis. , 2001, Clinical therapeutics.

[334] D. Foreman,et al. Is clinic prevalence of ICD-10 hyperkinesis underestimated? , 2001, European Child & Adolescent Psychiatry.

[335] S. Faraone,et al. The nature and heritability of attention-deficit/hyperactivity disorder. , 2001, Child and adolescent psychiatric clinics of North America.

[336] R. Milne,et al. Methylphenidate in children with hyperactivity: review and cost–utility analysis , 2001, Pharmacoepidemiology and drug safety.

[337] S. Faraone,et al. Adoptive and biological families of children and adolescents with ADHD. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[338] M. Monuteaux,et al. Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder , 2000, Genetic epidemiology.

[339] J. Biederman,et al. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. , 2000, Journal of child and adolescent psychopharmacology.

[340] E. Fombonne,et al. Psychopathology in adopted and nonadopted children: a clinical sample. , 1999, The American journal of orthopsychiatry.

[341] N Marlow,et al. Attention deficit hyperactivity disorders and other psychiatric outcomes in very low birthweight children at 12 years. , 1997, Journal of child psychology and psychiatry, and allied disciplines.

[342] M. Mcstephen,et al. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[343] W. Iacono,et al. Attention-deficit hyperactivity disorder dimensions: a twin study of inattention and impulsivity-hyperactivity. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[344] S. Faraone,et al. Pregnancy, delivery and infancy complications and attention deficit hyperactivity disorder: Issues of gene-environment interaction , 1997, Biological Psychiatry.

[345] Leonard M. Giambra,et al. Task‐unrelated thoughts of college students diagnosed as hyperactive in childhood , 1993 .

[346] N. Lie. Follow‐ups of children with attention delicit hyperactivity disorder (ADHD) , 1992 .

[347] B. Pennington,et al. A twin study of the etiology of comorbidity: attention-deficit hyperactivity disorder and dyslexia. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

[348] N. Lie. Follow-ups of children with attention deficit hyperactivity disorder (ADHD). Review of literature. , 1992, Acta psychiatrica Scandinavica. Supplementum.

[349] R. Klein,et al. Young adult mental status of hyperactive boys and their brothers: a prospective follow-up study. , 1991, Journal of the American Academy of Child and Adolescent Psychiatry.

[350] G. Weiss,et al. Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. , 1985, Journal of the American Academy of Child Psychiatry.

[351] P. Wender,et al. Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. , 1976, Archives of general psychiatry.